M. Delaforge
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
- Amino Acid Enzymes and Metabolism
Papers in
- Pharmacology 30
- Pharmacogenetics and Drug Metabolism 27
- Drug-Induced Hepatotoxicity and Protection 5
-
- Metabolomics and Mass Spectrometry Studies 5
- Cancer therapeutics and mechanisms 4
- Co-authors
- Daniel Mansuy (18 shared papers)Jean‐Luc Boucher (11 shared papers)Costas Ioannides (6 shared papers)D. V. Parke (5 shared papers)J. Custot (3 shared papers)Jean‐Pierre Tenu (2 shared papers)François André (5 shared papers)Jean‐Paul Renaud (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (10 papers)Chemico-Biological Interactions (5 papers)Drug Metabolism and Disposition (3 papers)Biochemical Pharmacology (3 papers)Xenobiotica (3 papers)
- Partner nations
- FranceUnited KingdomCanada
In The Last Decade
M. Delaforge
57 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Pharmacology 404
- Biochemistry 336
- Physiology 440
- Biophysics 54
- Pharmacology 138
Countries citing papers authored by M. Delaforge
This map shows the geographic impact of M. Delaforge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Delaforge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Delaforge more than expected).
Fields of papers citing papers by M. Delaforge
This network shows the impact of papers produced by M. Delaforge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Delaforge. The network helps show where M. Delaforge may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Delaforge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 154 | |
| 2 | 1992 | 119 | |
| 3 | 1995 | 102 | |
| 4 | 1993 | 93 | |
| 5 | 1981 | 93 | |
| 6 | 1989 | 90 | |
| 7 | 1997 | 88 | |
| 8 | 2007 | 66 | |
| 9 | 1992 | 58 | |
| 10 | 1989 | 55 | |
| 11 | 2004 | 39 | |
| 12 | 1982 | 38 | |
| 13 | 2004 | 38 | |
| 14 | 1980 | 34 | |
| 15 | 2010 | 33 | |
| 16 | 1997 | 29 | |
| 17 | 1984 | 28 | |
| 18 | 1986 | 26 | |
| 19 | 1981 | 23 | |
| 20 | 1989 | 22 |
About M. Delaforge
M. Delaforge is a scholar working on Pharmacology, Molecular Biology, Oncology, Biochemistry and Physiology, having authored 57 papers that have together received 1.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (27 papers), Drug Transport and Resistance Mechanisms (12 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Nitric Oxide and Endothelin Effects (9 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Pharmacology (404 citations), Biochemistry (336 citations), Physiology (440 citations), Biophysics (54 citations) and Pharmacology (138 citations). M. Delaforge has collaborated with scholars based in France, United Kingdom and Canada. Frequent co-authors include Daniel Mansuy, Jean‐Luc Boucher, Costas Ioannides, D. V. Parke, J. Custot, Jean‐Pierre Tenu, François André, Jean‐Paul Renaud, A. Yapo and Michel Lepoivre. Their work appears in journals such as Biochemical and Biophysical Research Communications, Chemico-Biological Interactions, Drug Metabolism and Disposition, Biochemical Pharmacology and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.